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 Mycobacterium tuberculosis remains one of the deadly pathogens, which are threa  for 
people around the world. The combination of antituberculotic drugs is effective but the 
treatment is prolonged and sometimes it is not successful because of multiresistant forms of 
tuberculosis and also co-infection with HIV, that are the problems in last a few years. 
Therefore, it is necessity to find a new drug against tuberculosis, which will be effective 
against resistant forms of mycobacterium and can be us d for HIV therapy. Enzyme 
isocitratelyase performs a potentially drug target against Mycobacterium tuberculosis. This 
enzyme plays a key role of glyoxylate pathway, where catalyzes the conversion of isocitrate 
to succinate and glyoxylate. This enzyme is necessary for mycobacterial survive during acute 
phase of the infection. 
 The aim of this work is to determine that the activity of isocitratelyase is inhibited by 
S-benzylisothiosemicarbazones and flavonoids and so they could be new potentially 
antituberculotic drugs. 
 Activity of this enzyme was determined by spectrofot metric method in our research 
and discovered on the basis of glyoxylate´s quantity in well plates. 
 Results of our study have shown low inhibition property of flavonoids - the most 
inhibit isocitratelyase (-)-epigallocatechine gallate and quercetin hydrate. These compounds 
of the group of S-benzylisothiosemicarbazones have had the most ability to inhibit 
isocitratelyase: 5-bromosalicylaldehyde-S-4-fluorbenzylisothiosemicarbazone, benzaldehyde-
S-4-brombenzylisothiosemicarbazone, salicylaldehyde-S-4-chlorbenzylisothiosemicarbazone 
and salicylaldehyde-S 4-bromobenzylisothiosemicarbazone. 
 
 
